Borbely, Gabor <br/><br/>
Induction of USP17 by combining BET and HDAC inhibitors in breast cancer cells.  [electronic resource] 

 -  Oncotarget  Oct 2015 
 - 33623-35 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1949-2553 
<br/><br/><label>Standard No.: </label>10.18632/oncotarget.5601  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Azepines--pharmacology<br/>Benzamides--pharmacology<br/>Breast Neoplasms--drug therapy<br/>Cell Cycle Proteins<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Drug Synergism<br/>Endopeptidases--biosynthesis<br/>Enzyme Induction--drug effects<br/>Female<br/>Histone Deacetylase Inhibitors--pharmacology<br/>Humans<br/>MAP Kinase Signaling System<br/>MCF-7 Cells<br/>Nuclear Proteins--antagonists & inhibitors<br/>Protein Serine-Threonine Kinases--antagonists & inhibitors<br/>Pyrimidines--pharmacology<br/>RNA, Small Interfering--administration & dosage<br/>RNA-Binding Proteins--antagonists & inhibitors<br/>Transcription Factors--antagonists & inhibitors<br/>Triazoles--pharmacology<br/>Up-Regulation--drug effects